Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 75

1.

Potential effect of anti-inflammatory drug use on PSA kinetics and subsequent prostate cancer diagnosis: Risk stratification in black and white men with benign prostate biopsy.

Kryvenko ON, Wang Y, Sadasivan S, Gupta NS, Rogers C, Bobbitt K, Chitale DA, Rundle A, Tang D, Rybicki BA.

Prostate. 2019 Jul;79(10):1090-1098. doi: 10.1002/pros.23820. Epub 2019 May 2.

PMID:
31045267
2.

Distribution and Short-term Prognostic Value of the 21-gene recurrence score in African American compared to White American breast cancer patients.

Amro A, Chen Y, Barry R, Susick L, Bensenhaver J, Proctor E, Petersen L, Nathanson SD, Ali H, Loutfi R, Chitale D, Simonds A, Kuklinski M, Park KU, Davis M, Newman LA.

Breast J. 2019 Jul;25(4):667-671. doi: 10.1111/tbj.13256. Epub 2019 Apr 25.

PMID:
31025467
3.

Atypical Chemokine Receptor 1 (DARC/ACKR1) in Breast Tumors Is Associated with Survival, Circulating Chemokines, Tumor-Infiltrating Immune Cells, and African Ancestry.

Jenkins BD, Martini RN, Hire R, Brown A, Bennett B, Brown I, Howerth EW, Egan M, Hodgson J, Yates C, Kittles R, Chitale D, Ali H, Nathanson D, Nikolinakos P, Newman L, Monteil M, Davis MB.

Cancer Epidemiol Biomarkers Prev. 2019 Apr;28(4):690-700. doi: 10.1158/1055-9965.EPI-18-0955.

PMID:
30944146
4.

HER2 Expression in NF1 Breast Cancer-Response.

Wang X, Chitale D.

Cancer Prev Res (Phila). 2019 Mar;12(3):197-198. doi: 10.1158/1940-6207.CAPR-18-0492. Epub 2019 Feb 21. No abstract available.

PMID:
30792347
5.

Germline and Somatic NF1 Alterations Are Linked to Increased HER2 Expression in Breast Cancer.

Wang X, Kallionpää RA, Gonzales PR, Chitale DA, Tousignant RN, Crowley JP, Chen Z, Yoder SJ, Blakeley JO, Acosta MT, Korf BR, Messiaen LM, Tainsky MA.

Cancer Prev Res (Phila). 2018 Oct;11(10):655-664. doi: 10.1158/1940-6207.CAPR-18-0072. Epub 2018 Aug 13.

PMID:
30104415
6.

Association between cadmium and androgen receptor protein expression differs in prostate tumors of African American and European American men.

Neslund-Dudas CM, McBride RB, Kandegedara A, Rybicki BA, Kryvenko ON, Chitale D, Gupta N, Williamson SR, Rogers CG, Cordon-Cardo C, Rundle AG, Levin AM, Dou QP, Mitra B.

J Trace Elem Med Biol. 2018 Jul;48:233-238. doi: 10.1016/j.jtemb.2018.04.006. Epub 2018 Apr 13.

7.

Utilization of the 21-Gene Recurrence Score in a Diverse Breast Cancer Patient Population: Development of a Clinicopathologic Model to Predict High-Risk Scores and Response to Neoadjuvant Chemotherapy.

Park KU, Chen Y, Chitale D, Choi S, Ali H, Nathanson SD, Bensenhaver J, Proctor E, Petersen L, Loutfi R, Simonds A, Kuklinski M, Doyle T, Dabak V, Cole K, Davis M, Newman L.

Ann Surg Oncol. 2018 Jul;25(7):1921-1927. doi: 10.1245/s10434-018-6440-7. Epub 2018 Apr 20.

PMID:
29679201
8.

Pseudosarcomatous myofibroblastic proliferations of the genitourinary tract are genetically different from nodular fasciitis and lack USP6, ROS1 and ETV6 gene rearrangements.

Jebastin JAS, Smith SC, Perry KD, Gupta NS, Alanee S, Carskadon S, Chitale DA, Palanisamy N, Williamson SR.

Histopathology. 2018 Aug;73(2):321-326. doi: 10.1111/his.13526. Epub 2018 May 30.

PMID:
29617048
9.

Ecchymotic Nodule on the Scalp: Challenge.

Saleh J, Ozog DM, Chitale DA, Friedman BJ.

Am J Dermatopathol. 2018 Mar 21. doi: 10.1097/DAD.0000000000001140. [Epub ahead of print] No abstract available.

PMID:
29570134
10.

Triple-Negative Breast Cancer, Stem Cells, and African Ancestry.

Jiagge E, Chitale D, Newman LA.

Am J Pathol. 2018 Feb;188(2):271-279. doi: 10.1016/j.ajpath.2017.06.020. Epub 2017 Nov 11. Review.

PMID:
29137951
11.

Pleomorphic fibroma of the skin with MDM2 immunoreactivity: A potential diagnostic pitfall.

Tashakori M, Pimentel J, Howitt BE, Sanchez J, Michalowski S, Chitale D, Ormsby AH, Williamson SR.

J Cutan Pathol. 2018 Jan;45(1):59-62. doi: 10.1111/cup.13052. Epub 2017 Nov 8.

PMID:
28981153
12.

Breast cancer risk and germline genomic profiling of women with neurofibromatosis type 1 who developed breast cancer.

Wang X, Teer JK, Tousignant RN, Levin AM, Boulware D, Chitale DA, Shaw BM, Chen Z, Zhang Y, Blakeley JO, Acosta MT, Messiaen LM, Korf BR, Tainsky MA.

Genes Chromosomes Cancer. 2018 Jan;57(1):19-27. doi: 10.1002/gcc.22503. Epub 2017 Sep 30.

PMID:
28891274
13.

Bioenergetic Adaptations in Chemoresistant Ovarian Cancer Cells.

Dar S, Chhina J, Mert I, Chitale D, Buekers T, Kaur H, Giri S, Munkarah A, Rattan R.

Sci Rep. 2017 Aug 18;7(1):8760. doi: 10.1038/s41598-017-09206-0.

14.

Renal cell tumors with clear cell histology and intact VHL and chromosome 3p: a histological review of tumors from the Cancer Genome Atlas database.

Favazza L, Chitale DA, Barod R, Rogers CG, Kalyana-Sundaram S, Palanisamy N, Gupta NS, Williamson SR.

Mod Pathol. 2017 Nov;30(11):1603-1612. doi: 10.1038/modpathol.2017.72. Epub 2017 Jul 21.

15.

Methylation markers differentiate thyroid cancer from benign nodules.

Stephen JK, Chen KM, Merritt J, Chitale D, Divine G, Worsham MJ.

J Endocrinol Invest. 2018 Feb;41(2):163-170. doi: 10.1007/s40618-017-0702-2. Epub 2017 Jun 13.

PMID:
28612287
16.

Larger men have larger prostates: Detection bias in epidemiologic studies of obesity and prostate cancer risk.

Rundle A, Wang Y, Sadasivan S, Chitale DA, Gupta NS, Tang D, Rybicki BA.

Prostate. 2017 Jun;77(9):949-954. doi: 10.1002/pros.23350. Epub 2017 Mar 27.

17.

Evaluation and Adaptation of a Laboratory-Based cDNA Library Preparation Protocol for Retrospective Sequencing of Archived MicroRNAs from up to 35-Year-Old Clinical FFPE Specimens.

Loudig O, Wang T, Ye K, Lin J, Wang Y, Ramnauth A, Liu C, Stark A, Chitale D, Greenlee R, Multerer D, Honda S, Daida Y, Spencer Feigelson H, Glass A, Couch FJ, Rohan T, Ben-Dov IZ.

Int J Mol Sci. 2017 Mar 14;18(3). pii: E627. doi: 10.3390/ijms18030627.

18.

The biological significance of methylome differences in human papilloma virus associated head and neck cancer.

Worsham MJ, Chen KM, Datta I, Stephen JK, Chitale D, Gothard A, Divine G.

Oncol Lett. 2016 Dec;12(6):4949-4956. doi: 10.3892/ol.2016.5303. Epub 2016 Oct 21.

19.

Renal Cell Carcinoma With Chromosome 6p Amplification Including the TFEB Gene: A Novel Mechanism of Tumor Pathogenesis?

Williamson SR, Grignon DJ, Cheng L, Favazza L, Gondim DD, Carskadon S, Gupta NS, Chitale DA, Kalyana-Sundaram S, Palanisamy N.

Am J Surg Pathol. 2017 Mar;41(3):287-298. doi: 10.1097/PAS.0000000000000776.

PMID:
28009604
20.

Association Between Benign Breast Disease in African American and White American Women and Subsequent Triple-Negative Breast Cancer.

Newman LA, Stark A, Chitale D, Pepe M, Longton G, Worsham MJ, Nathanson SD, Miller P, Bensenhaver JM, Proctor E, Swain M, Patriotis C, Engstrom PF.

JAMA Oncol. 2017 Aug 1;3(8):1102-1106. doi: 10.1001/jamaoncol.2016.5598.

21.

The predictive value of increased sentinel lymph node volume in breast cancer.

Krasnick BA, Nathanson SD, Arbabi CN, Chitale DA, Peterson EL.

Surg Oncol. 2016 Sep;25(3):321-5. doi: 10.1016/j.suronc.2016.06.002. Epub 2016 Jun 24.

PMID:
27566039
22.

Comparative Analysis of Breast Cancer Phenotypes in African American, White American, and West Versus East African patients: Correlation Between African Ancestry and Triple-Negative Breast Cancer.

Jiagge E, Jibril AS, Chitale D, Bensenhaver JM, Awuah B, Hoenerhoff M, Adjei E, Bekele M, Abebe E, Nathanson SD, Gyan K, Salem B, Oppong J, Aitpillah F, Kyei I, Bonsu EO, Proctor E, Merajver SD, Wicha M, Stark A, Newman LA.

Ann Surg Oncol. 2016 Nov;23(12):3843-3849. Epub 2016 Jul 28.

PMID:
27469125
23.

Investigation into the presence of human papillomavirus in patients with obstructive sleep apnea.

Baldwin BJ, Chitale D, Chen KM, Worsham MJ, Yaremchuk K.

Laryngoscope. 2017 May;127(5):1231-1234. doi: 10.1002/lary.26175. Epub 2016 Jul 14.

PMID:
27412085
24.

Biological significance of genome-wide DNA methylation profiles in keloids.

Jones LR, Greene J, Chen KM, Divine G, Chitale D, Shah V, Datta I, Worsham MJ.

Laryngoscope. 2017 Jan;127(1):70-78. doi: 10.1002/lary.26063. Epub 2016 Jun 16.

PMID:
27312686
25.

Methylation Markers for Early Detection and Differentiation of Follicular Thyroid Cancer Subtypes.

Stephen JK, Chen KM, Merritt J, Chitale D, Divine G, Worsham MJ.

Cancer Clin Oncol. 2015 Nov;4(2):1-12. Epub 2015 Jun 15.

26.

Anti-androgenic activity of absorption-enhanced 3, 3'-diindolylmethane in prostatectomy patients.

Hwang C, Sethi S, Heilbrun LK, Gupta NS, Chitale DA, Sakr WA, Menon M, Peabody JO, Smith DW, Sarkar FH, Heath EI.

Am J Transl Res. 2016 Jan 15;8(1):166-76. eCollection 2016.

27.

Mutational Landscape of Aggressive Prostate Tumors in African American Men.

Lindquist KJ, Paris PL, Hoffmann TJ, Cardin NJ, Kazma R, Mefford JA, Simko JP, Ngo V, Chen Y, Levin AM, Chitale D, Helfand BT, Catalona WJ, Rybicki BA, Witte JS.

Cancer Res. 2016 Apr 1;76(7):1860-8. doi: 10.1158/0008-5472.CAN-15-1787. Epub 2016 Feb 26.

28.

Methylation in benign prostate and risk of disease progression in men subsequently diagnosed with prostate cancer.

Rybicki BA, Rundle A, Kryvenko ON, Mitrache N, Do KC, Jankowski M, Chitale DA, Trudeau S, Belinsky SA, Tang D.

Int J Cancer. 2016 Jun 15;138(12):2884-93. doi: 10.1002/ijc.30038. Epub 2016 Mar 2.

29.

Racial differences in the relationship between clinical prostatitis, presence of inflammation in benign prostate and subsequent risk of prostate cancer.

Rybicki BA, Kryvenko ON, Wang Y, Jankowski M, Trudeau S, Chitale DA, Gupta NS, Rundle A, Tang D.

Prostate Cancer Prostatic Dis. 2016 Jun;19(2):145-50. doi: 10.1038/pcan.2015.54. Epub 2015 Dec 1.

30.

Autoantibodies in breast cancer sera are not epiphenomena and may participate in carcinogenesis.

Madrid FF, Maroun MC, Olivero OA, Long M, Stark A, Grossman LI, Binder W, Dong J, Burke M, Nathanson SD, Zarbo R, Chitale D, Zeballos-Chávez R, Peebles C.

BMC Cancer. 2015 May 15;15:407. doi: 10.1186/s12885-015-1385-8.

31.

Cell signaling events differentiate ER-negative subtypes from ER-positive breast cancer.

Worsham MJ, Chitale D, Chen KM, Datta I, Divine G.

Med Oncol. 2015 May;32(5):142. doi: 10.1007/s12032-015-0565-3. Epub 2015 Mar 25.

PMID:
25805566
32.

Inhibition of 5-lipoxygenase selectively triggers disruption of c-Myc signaling in prostate cancer cells.

Sarveswaran S, Chakraborty D, Chitale D, Sears R, Ghosh J.

J Biol Chem. 2015 Feb 20;290(8):4994-5006. doi: 10.1074/jbc.M114.599035. Epub 2014 Dec 24.

33.

Anti-centrosome antibodies in breast cancer are the expression of autoimmunity.

Maroun MC, Olivero O, Lipovich L, Stark A, Tait L, Bandyopadhyay S, Burke M, Zarbo R, Chitale D, David Nathanson S, Long M, Peebles C, Madrid FF.

Immunol Res. 2014 Dec;60(2-3):339-47. doi: 10.1007/s12026-014-8582-4.

PMID:
25420961
34.

Array-CGH shows amplification of 8q including MYC as the sole aberration in a leiomyosarcoma of the female lower genital tract.

Barnabas N, Sanchez J, Chitale D, Adeyinka A.

Cytogenet Genome Res. 2014;142(4):245-8. doi: 10.1159/000362523. Epub 2014 May 9.

PMID:
24820857
35.

Admixture fine-mapping in African Americans implicates XAF1 as a possible sarcoidosis risk gene.

Levin AM, Iannuzzi MC, Montgomery CG, Trudeau S, Datta I, Adrianto I, Chitale DA, McKeigue P, Rybicki BA.

PLoS One. 2014 Mar 24;9(3):e92646. doi: 10.1371/journal.pone.0092646. eCollection 2014.

36.

Erratum: Epigenetic silencing of miR-34a in human prostate cancer cells and tumor tissue specimens can be reversed by BR-DIM treatment.

Kong D, Heath E, Chen W, Cher M, Powell I, Heilbrun L, Li Y, Ali S, Sethi S, Hassan O, Hwang C, Gupta N, Chitale D, Sakr W, Menon M, Sarkar F.

Am J Transl Res. 2013 Dec 1;6(1):102-103. eCollection 2013.

37.

Intraoperative clinical assessment and pressure measurements of sentinel lymph nodes in breast cancer.

Nathanson SD, Shah R, Chitale DA, Mahan M.

Ann Surg Oncol. 2014 Jan;21(1):81-5. doi: 10.1245/s10434-013-3249-2. Epub 2013 Sep 18.

PMID:
24046111
38.

Significance of p16 in Site-specific HPV Positive and HPV Negative Head and Neck Squamous Cell Carcinoma.

Stephen JK, Divine G, Chen KM, Chitale D, Havard S, Worsham MJ.

Cancer Clin Oncol. 2013;2(1):51-61.

39.

Prevalence of terminal duct lobular units and frequency of neoplastic involvement of the nipple in mastectomy.

Kryvenko ON, Yoon JY, Chitale DA, Lee MW.

Arch Pathol Lab Med. 2013 Jul;137(7):955-60. doi: 10.5858/arpa.2012-0137-OA.

PMID:
23808467
40.

Precursor lesions of mucinous carcinoma of the breast: analysis of 130 cases.

Kryvenko ON, Chitale DA, Yoon J, Arias-Stella J 3rd, Meier FA, Lee MW.

Am J Surg Pathol. 2013 Jul;37(7):1076-84. doi: 10.1097/PAS.0b013e31828de420.

PMID:
23759933
41.

Adenomyoepithelioma of the breast: a brief diagnostic review.

Yoon JY, Chitale D.

Arch Pathol Lab Med. 2013 May;137(5):725-9. doi: 10.5858/arpa.2011-0404-RS. Review.

PMID:
23627458
42.

Immunohistochemical staining with EGFR mutation-specific antibodies: high specificity as a diagnostic marker for lung adenocarcinoma.

Wen YH, Brogi E, Hasanovic A, Ladanyi M, Soslow RA, Chitale D, Shia J, Moreira AL.

Mod Pathol. 2013 Sep;26(9):1197-203. doi: 10.1038/modpathol.2013.53. Epub 2013 Apr 19.

43.

Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology.

Lindeman NI, Cagle PT, Beasley MB, Chitale DA, Dacic S, Giaccone G, Jenkins RB, Kwiatkowski DJ, Saldivar JS, Squire J, Thunnissen E, Ladanyi M, College of American Pathologists International Association for the Study of Lung Cancer and Association for Molecular Pathology.

J Mol Diagn. 2013 Jul;15(4):415-53. doi: 10.1016/j.jmoldx.2013.03.001. Epub 2013 Apr 4. Erratum in: J Mol Diagn. 2013 Sep;15(5):730.

44.

Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology.

Lindeman NI, Cagle PT, Beasley MB, Chitale DA, Dacic S, Giaccone G, Jenkins RB, Kwiatkowski DJ, Saldivar JS, Squire J, Thunnissen E, Ladanyi M.

J Thorac Oncol. 2013 Jul;8(7):823-59. doi: 10.1097/JTO.0b013e318290868f. Erratum in: J Thorac Oncol. 2013 Oct;8(10):1343.

45.

Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology.

Lindeman NI, Cagle PT, Beasley MB, Chitale DA, Dacic S, Giaccone G, Jenkins RB, Kwiatkowski DJ, Saldivar JS, Squire J, Thunnissen E, Ladanyi M.

Arch Pathol Lab Med. 2013 Jun;137(6):828-60. doi: 10.5858/arpa.2012-0720-OA. Epub 2013 Apr 3. Erratum in: Arch Pathol Lab Med. 2013 Sep;137(9):1174.

46.

Differential expression of aurora-A kinase in T-cell lymphomas.

Kanagal-Shamanna R, Lehman NL, O'Donnell JP, Lim MS, Schultz DS, Chitale DA, Bueso-Ramos CE, Medeiros LJ, Inamdar KV.

Mod Pathol. 2013 May;26(5):640-7. doi: 10.1038/modpathol.2012.211. Epub 2013 Feb 15.

47.

Methylation of the RARB gene increases prostate cancer risk in black Americans.

Tang D, Kryvenko ON, Mitrache N, Do KC, Jankowski M, Chitale DA, Trudeau S, Rundle A, Belinsky SA, Rybicki BA.

J Urol. 2013 Jul;190(1):317-24. doi: 10.1016/j.juro.2013.01.083. Epub 2013 Jan 30.

48.

Reliability of KRAS mutation testing in metastatic colorectal cancer patients across five laboratories.

Feigelson HS, Goddard KA, Johnson MA, Funk KC, Rahm AK, Kauffman TL, Chitale DA, Le Marchand L, Richards CS.

BMC Res Notes. 2012 Apr 25;5:196. doi: 10.1186/1756-0500-5-196.

49.

Inflammation and preneoplastic lesions in benign prostate as risk factors for prostate cancer.

Kryvenko ON, Jankowski M, Chitale DA, Tang D, Rundle A, Trudeau S, Rybicki BA.

Mod Pathol. 2012 Jul;25(7):1023-32. doi: 10.1038/modpathol.2012.51. Epub 2012 Mar 30. Erratum in: Mod Pathol. 2013 Mar;26(3):464.

50.

Loss of let-7 up-regulates EZH2 in prostate cancer consistent with the acquisition of cancer stem cell signatures that are attenuated by BR-DIM.

Kong D, Heath E, Chen W, Cher ML, Powell I, Heilbrun L, Li Y, Ali S, Sethi S, Hassan O, Hwang C, Gupta N, Chitale D, Sakr WA, Menon M, Sarkar FH.

PLoS One. 2012;7(3):e33729. doi: 10.1371/journal.pone.0033729. Epub 2012 Mar 19.

Supplemental Content

Loading ...
Support Center